The Central Social Insurance Medical Council, a key Japanese reimbursement policy panel better known as Chuikyo, approved an outline of…
HOME > REGULATORY
REGULATORY
- Korosho Begins Discussions Toward Integrating Senshin-iryo, Kohdo-iryo Systems
March 15, 2012
- Dr Sakurai of PMDA Stresses Need for Japan’s Participation in PIC/S to Create Global Inspection System
March 14, 2012
- Dissolution of Gliclazide Tablets Attributed to Large Particle Size: Generic Drug Quality Study Group
March 13, 2012
- Convincing Data Needed to Perpetuate Premium for New Drug Development: Mr Yoshida of MED
March 13, 2012
- Gov’t Releases Some Documents Related to Draft Statement on Iressa Lawsuits
March 13, 2012
- MHLW Announces Requirements for “Clinical Research Core Hospitals”
March 12, 2012
- Study Group to Discuss Whether “ABC” Screening Should Be Included in Gastric Cancer Screening: Parliamentary Secretary Fujita
March 9, 2012
- DPJ’s PAL Subcommittee to Begin Compiling Recommendations in Mid-March; Timing of Bill Unclear
March 7, 2012
- Aricept to Receive 16.7-16.8% Reduction, Lyrica 25% in Re-Pricing Due to Market Expansion
March 6, 2012
- 702 Products Including DPP-4 Inhibitors to Be Eligible for New Drug Premium in April
March 5, 2012
- Private-Sector Members of Strategy Council Call for Early Establishment of Drug Discovery Support Organization
March 5, 2012
- Cancer Policy Promotion Council Submits New 5-Year Plan to Health Minister Komiyama
March 5, 2012
- Revised Ordinance Banning “Dispensing Point” Services Announced in Official Gazette
March 5, 2012
- 11 APIs/28 Products to Receive Premiums for New Pediatric, Orphan Indications
March 5, 2012
- PAFSC’s 2nd Committee on Drugs Recommends Approval for Pfizer Japan’s ALK Inhibitor Xalkori
March 1, 2012
- MHLW Study Group Approves Outline of “Post-5-Year Plan” for Promoting Clinical Trials
March 1, 2012
- PAFSC’s 2nd Committee on Drugs Recommends Orphan Drug Designation for 4 Products
February 29, 2012
- MHLW Conducts Hearing on Distribution Improvement with Drug Manufacturers
February 28, 2012
- Ikoma City Introduces Pharmacy Certification System to Promote Use of Generics
February 28, 2012
- Non-partisan Study Group Holds Hearings on Problem of Essential But Unprofitable Drugs
February 28, 2012
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…